Analysts Point To First Majestic Silver Corporation (NYSE: AG) Growth In The Future

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Recently, Yahoo Finance discussed the stock, revealing that First Majestic Produces 6.6 Million AgEq Oz in Q4 2023 and 26.9 Million AgEq Oz in 2023; Announces 2024 Production and Cost Guidance and Conference Call Details.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

As a NYSE listed company, AG falls under the Basic Materials sector while operating within the Silver industry segment. At the end of the last regular session, the stock closed at $4.60 and fluctuated between $4.7300 as its day high and $4.5500 as its day low. The current market capitalization of First Majestic Silver Corporation is $1.32B. A total of 5.18 million shares were traded on the day, compared to an average of 6.76M shares.


Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. AG’s most recent ex-dividend date was 11/14/2023 when it declared a $0.0046 quarterly dividend that was paid in cash on 11/30/2023. Previously, the company paid the dividend on 8/31/2023 with an ex-dividend date of 8/15/2023. The AG stock dividend was $0.0050 per share in cash.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for AG in the last 3 months, the mean price target is $6.07 with high estimates of $6.75 and low estimates of $5.50. In terms of 52-week highs and lows, AG has a high of $8.07 and a low of $4.38.

As of this writing, AG has an earnings estimate of $, Inc. per share for the current quarter. EPS was calculated based on a consensus of MorphoSys AG estimates, with a high estimate of $CRISPR Therapeutics AG per share and a lower estimate of $Procter & Gamble Company (The).

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. AG’s latest balance sheet shows that the firm has $264.41M in Cash & Short Term Investments as of fiscal 2021. There were $221.09M in debt and $172.82M in liabilities at the time. Its Book Value Per Share was $4.67, while its Total Shareholder’s Equity was $1.41B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AG is Buy with a score of 3.33.

Most Popular

Related Posts